Free Trial

Rani Therapeutics (RANI) Institutional Ownership

Rani Therapeutics logo
$0.49 +0.02 (+4.16%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$0.54 +0.05 (+11.25%)
As of 05:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Rani Therapeutics (NASDAQ:RANI)

Current
Institutional Ownership
Percentage
30.19%
Number of
Institutional Buyers
(last 12 months)
13
Total
Institutional Inflows
(last 12 months)
$3.21M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$106.69K
Get RANI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rani Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

RANI Institutional Buying and Selling by Quarter

Rani Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2025 Armistice Capital LLC3,151,354$1.62M0.0%N/A4.986%
7/17/2025 Janney Montgomery Scott LLC55,200$28K0.0%+102.9%0.087%
7/15/2025 Well Done LLC52,014$27K0.0%N/A0.090%
5/12/2025 King Luther Capital Management Corp58,000$73K0.0%+75.8%0.101%
5/5/2025 Kestra Private Wealth Services LLC139,156$175K0.0%+16.3%0.242%
4/21/2025 CWA Asset Management Group LLC83,333$105K0.0%N/A0.145%
2/17/2025 Two Sigma Advisers LP110,163$151K0.0%N/A0.192%
2/17/2025 Two Sigma Investments LP291,381$399K0.0%N/A0.509%
2/17/2025 Bridgeway Capital Management LLC56,500$77K0.0%-21.0%0.099%
2/13/2025 Insigneo Advisory Services LLC47,500$65K0.0%N/A0.083%
2/12/2025 Takeda Pharmaceutical Co. Ltd.203,190$278K1.0%N/A0.355%
2/11/2025 Virtu Financial LLC45,404$62K0.0%N/A0.079%
2/7/2025 King Luther Capital Management Corp33,000$45K0.0%-59.3%0.058%
1/17/2025 Janney Montgomery Scott LLC27,200$37K0.0%N/A0.047%
11/16/2024 Geode Capital Management LLC172,261$372K0.0%+14.3%0.323%
11/15/2024 United Services Automobile Association302,743$654K0.0%-3.0%0.567%
11/15/2024 Stifel Financial Corp269,768$583K0.0%+100.4%0.505%
11/8/2024 King Luther Capital Management Corp81,129$175K0.0%+44.5%0.152%
8/14/2024 Marshall Wace LLP21,247$81K0.0%N/A0.042%
8/9/2024 Renaissance Technologies LLC21,700$82K0.0%-69.1%0.043%
8/7/2024 United Services Automobile Association312,095$1.19M0.0%-35.2%0.619%
5/10/2024 Vanguard Group Inc.685,303$2.13M0.0%+2.5%1.366%
2/14/2024Alpha Square Group S LLC58,946$196K0.2%-32.2%0.118%
8/10/2023 King Luther Capital Management Corp56,129$231K0.0%N/A0.113%
8/4/2023 Choreo LLC19,813$82K0.0%-20.2%0.040%
5/11/2023Icon Wealth Partners LLC12,757$66K0.0%N/A0.026%
5/11/2023 Alphabet Inc.448,492$2.31M0.1%-12.1%0.908%
2/8/2023 Prime Capital Investment Advisors LLC33,502$198K0.0%N/A0.068%
11/18/2022TPB Wealth Advisors48,129$461K0.2%-33.0%0.098%
11/16/2022 Alphabet Inc.714,471$6.85M0.3%N/A1.453%
11/3/2022 Motco48,129$461K0.0%N/A0.098%
10/28/2022 Lafayette Investments Inc.19,893$191K0.1%N/A0.040%
10/17/2022 Canton Hathaway LLC16,200$155K0.1%+88.4%0.033%
10/14/2022 Iowa State Bank18,862$181K0.1%N/A0.038%
8/8/2022 Islay Capital Management LLC9,611$99K0.1%N/A0.020%
8/8/2022Crossvault Capital Management LLC14,285$148K0.1%N/A0.029%
7/29/2022Aspireon Wealth Advisors71,811$742K0.3%N/A0.146%
7/20/2022 Canton Hathaway LLC8,600$89K0.0%N/A0.017%
6/15/2022 Lasry Marc62,828$848K0.4%N/A0.128%
5/17/2022 Lasry Marc62,828$848K0.4%N/A0.128%
Retire Comfortably with These New Monthly Income ETFs? (Ad)

Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns just aren’t enough anymore. But what if you could reach your Freedom Number—the monthly income that makes retirement secure—using far less money than you thought possible? That’s exactly what Kelly G. discovered. She calls it “life-changing,” saying the income just keeps growing and that early retirement suddenly looks real. This strategy was once reserved for the ultra-wealthy, but it’s now available to everyday investors.tc pixel

Click here to watch the free presentation and learn how to calculate your personal Freedom Number—an
5/13/2022 United Services Automobile Association481,300$6.50M0.1%N/A0.979%
2/3/2022 Advisor Group Holdings Inc.21,072$344K0.0%N/A0.043%
1/6/2022 Canton Hathaway LLC5,000$82K0.0%-50.0%0.010%
11/16/2021 Squarepoint Ops LLC50,000$891K0.0%N/A0.102%
11/15/2021Caas Capital Management LP75,000$1.34M0.0%N/A0.153%
11/10/2021 Goldman Sachs Group Inc.60,649$1.08M0.0%N/A0.124%
(Data available from 1/1/2016 forward)

RANI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RANI shares?

During the previous two years, 19 institutional investors and hedge funds held shares of Rani Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($2.13M), Armistice Capital LLC ($1.62M), United Services Automobile Association ($654K), Stifel Financial Corp ($583K), Two Sigma Investments LP ($399K), Geode Capital Management LLC ($372K), and Takeda Pharmaceutical Co. Ltd. ($278K).Learn more on Rani Therapeutics' institutional investors.

What percentage of Rani Therapeutics' stock is owned by institutional investors?

30.19% of Rani Therapeutics' stock is owned by institutional investors. Learn more on RANI's institutional investor holdings.

Which institutional investors have been buying Rani Therapeutics' stock?

Of the 15 institutional investors that purchased Rani Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($3.15M), Two Sigma Investments LP ($291.38K), Takeda Pharmaceutical Co. Ltd. ($203.19K), Stifel Financial Corp ($135.15K), Two Sigma Advisers LP ($110.16K), CWA Asset Management Group LLC ($83.33K), and Janney Montgomery Scott LLC ($55.20K).

How much institutional buying is happening at Rani Therapeutics?

Institutional investors have bought a total of 4,265,750 shares in the last 24 months. This purchase volume represents approximately $3.21M in transactions.

Which of Rani Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Rani Therapeutics stock in the last 24 months: King Luther Capital Management Corp ($48.13K), Bridgeway Capital Management LLC ($15K), and United Services Automobile Association ($9.35K).

How much institutional selling is happening at Rani Therapeutics?

Institutional investors have sold a total of 72,481 shares in the last 24 months. This volume of shares sold represents approximately $106.69K in transactions.



This page (NASDAQ:RANI) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners